Tranylcypromine
PARNATE
NADAC/unit
$0.6384
No Shortage
Tier 1: 21.3%
3 Manufacturers
3 ANDAs
vs. brand PARNATE: Generic saves up to 94% per unit
Active Shortages
2025-10-21 Supply is expected to be depleted by 12/31/2025., Teva Pharmaceuticals USA, Inc.
Generic Manufacturers
ADVANZ PHARMA (US) CORPCROSSMEDIKA SANOVITIUM PHARMA LLCSTRIDES PHARMA INTERNATIONAL AG
Explore in the Ecosystem
Data sourced from CMS NADAC, FDA Orange Book, CMS Part D Formulary, CMS Part D Spending, openFDA, and HRSA 340B OPAIS. Prices reflect National Average Drug Acquisition Cost and may not represent actual transaction prices. This information is for research and comparison purposes only. Consult your pharmacist or benefits consultant for plan-specific pricing.